Novartis AG
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $15.07B | $14.01B | $1.07B | $910.0M |
| FY2022 | $14.24B | $13.32B | $916.0M | $982.0M |
| FY2023 | $14.46B | $13.40B | $1.06B | $1.14B |
| FY2024 | $17.62B | $16.25B | $1.37B | $1.31B |
| FY2025 | $19.14B | $17.60B | $1.55B | $1.33B |